Managed Healthcare Executive May 17, 2021
Dr. Vivian Lee of Verily Life Sciences addresses if value-based care programs have steered U.S healthcare away from the problems of fee-for-service at a virtual ISPOR meeting today. Lee also shares her thoughts on if the pandemic changed her views of American healthcare.
Dr. Vivian Lee of Verily Life Sciences believes there have been some really fantastic efforts to move the country to value-based care with great initiatives and pilot projects, however, at this time, we probably haven’t seen the full transformation, the full impact of these programs.
Lee, who is president of health platforms at Verily Life Sciences, a healthcare data subsidiary of Alphabet, Google’s parent company, was one of the speakers in the opening plenary session this morning...
Today's Sponsors
Today's Sponsor